SCHEMBL9008090

SCHEMBL9008090

CCCCCCCC1CCC(CCCCCCC)C(C(=O)Nc2c(SC)cc(C)nc2SC)S1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SOAT1 P35610 6/20 0.35
▸ NR1I2 O75469 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9008139 1.00 SOAT1 (0.35) SOAT1NR1I2KDM4E
SCHEMBL9008067 1.00 SOAT1 (0.35) SOAT1NR1I2KDM4E
SCHEMBL9008152 0.99 SOAT1 (0.36) SOAT1NR1I2KDM4E
SCHEMBL9008076 0.96 SOAT1 (0.36) SOAT1NR1I2KDM4E
SCHEMBL9008128 0.92 SOAT1 (0.36) SOAT1
SCHEMBL9008269 0.91 SOAT1 (0.39) SOAT1
SCHEMBL9008145 0.85 DDAH1 (0.35) SOAT1
SCHEMBL9008099 0.81 SOAT1 (0.36) SOAT1
SCHEMBL13716597 0.80 SOAT1 (0.35) SOAT1
SCHEMBL13716632 0.79 SOAT1 (0.35) SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5491152-A Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-02-13 — — US disclosed
Send feedback